Progress in Mind Portugal Your Psychiatry & Neurology Resource Center COVID-19 Learn more ECNP 21 Learn more Medical education resource center Do you want to learn more? Medical education resource center The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology. Learn More THINC® Focus on cognitive symptoms in depression See More Recent News AllDepressionMigraineSchizophrenia Migraine 07 Feb, 2022 Read Time: 2 mins Congress highlights Is communication between meningeal immune cells and neurons a critical factor in migraine? How might meningeal immune cells influence neural activity and lead to the symptoms of migraine?... Migraine 30 Dec, 2021 Read Time: 2 mins Congress highlights Impact of abuse on migraine symptoms and comorbidity Emotional, physical, and sexual abuse are associated with an increased risk for developing migraine.... Migraine 16 Dec, 2021 Read Time: 3 mins Satellite symposium What happens in the brain and meninges during a migraine attack? Understanding the relationships between brain activation and migraine symptoms is fundamental to... Schizophrenia 06 Dec, 2021 Read Time: 4 mins Satellite symposium The COVID-19 pandemic and mental health - impact and implications One of the goals of the European College of Neuropsychopharmacology (ECNP) is to facilitate the... Migraine 06 Dec, 2021 Read Time: 3 mins Congress highlights New insights from posters at IHC2021 on how COVID-19 tests and lockdowns have affected patients with migraine Does a nasopharyngeal swab for COVID-19 trigger migraineand what has been the impact of COVID-19... Depression, Schizophrenia 02 Dec, 2021 Read Time: 5 mins Satellite symposium Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In an... Migraine 01 Dec, 2021 Read Time: 4 mins Congress highlights The omics and migraine The omics — genomics, epigenomics, pharmacogenomics, proteomics and metabolomics — are increasing... Depression 17 Nov, 2021 Read Time: 2 mins Congress highlights Melancholic MDD: different presentation and treatment but same response Even if melancholic features represent more severe depression, clinicians seem to have developed... Migraine 15 Nov, 2021 Read Time: 2 mins Congress highlights New insights from a poster at IHC2021 on the depiction of migraine in the media How realistic is the presentation of migraine in the media? Does it help raise awareness and lessen... Migraine 11 Nov, 2021 Read Time: 3 mins Congress highlights Insights into migraine mechanisms: a central brain disorder with peripheral inputs Speaking at #WCN2021, Professor Todd Schwedt, of the Mayo Clinic, USA summarized that although there... Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page » Depression, Schizophrenia 09 Aug, 2019 Video #3: Shared decision-making and therapeutic alliance in schizophrenia Depression 04 Jun, 2019 Read Time: 4 mins Satellite symposium Treatment outcomes that matter – established and emerging therapies for patients with major depressive disorder who do not respond adequately to antidepressants Major depressive disorder (MDD) has significant costs to society and is predicted to be the leading... Depression 04 Jun, 2019 Read Time: 4 mins Congress highlights Immune modulation in psychiatric disorders: Are we there yet? It has been argued that drug discovery for psychiatric disorders is at a near standstill. Which... Mental Health 21 May, 2019 Read Time: 3 mins Congress highlights What is the role of inflammation in the pathophysiology of mood disorders? Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology and... Mental Health 21 May, 2019 Read Time: 3 mins Congress highlights A public invitation to view and comment on pre-final APA schizophrenia guideline statements Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two... Mental Health 14 May, 2019 Read Time: 3 mins Congress highlights Challenges for social psychiatry in a changing world Modern social risk factors for the development of severe psychiatric disorders, such as migration and... Depression, Schizophrenia 13 May, 2019 Read Time: 5 mins Congress highlights Lifestyle, the gut, and mental health Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of... Mental Health 09 May, 2019 Read Time: 4 mins Congress highlights Social isolation and stigma: Cross-cultural perspectives Meaningful connection to other people is as essential to health as the air we breathe. So the stigma... Depression 15 Apr, 2019 Read Time: 5 mins Article Clinical Use of Body-Swapping! Don’t worry, it’s Virtual Reality! Digital technologies are unfamiliar to many physicians, yet there is a huge demand for their... Mental Health 15 Apr, 2019 Read Time: 4 mins Congress highlights Psychiatrist and patient partnership encourages trust and effective care We have so many shared objectives – notably ensuring adequate resources are given to mental health –... Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page » Migraine 09 Aug, 2021 Read Time: 3 mins Congress highlights Does migraine alter COVID-19 susceptibility? In a late-breaking abstract presentation at #AHSAM21, Professor Robert Shapiro, University of... Migraine 26 Jul, 2021 Read Time: 3 mins Congress highlights Preventive treatment gaps and priorities in migraine Speaking at #ASHAM21, Dr Stephanie Nahas, Thomas Jefferson University, identified that only a... Migraine 21 Jul, 2021 Read Time: 3 mins Congress highlights COVID-19 vaccines, migraine, and preventives: any evidence of interactions? The advent of COVID-19 vaccines has raised questions on whether vaccines impact on the management of... Migraine 05 Jul, 2021 Read Time: 2 mins Congress highlights CGRP has a role in infection-induced pain While the role of calcitonin gene-related peptide (CGRP) in headache and migraine is well... Migraine, Alzheimer's Disease 22 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 4 Today, 22 June, Day 4 of the 7th Congress of the European Academy of Neurology – Vienna 2021, was the... Migraine, Alzheimer's Disease 21 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 3 Progress in Mind’s coverage of the 7th Congress of the European Academy of Neurology – Vienna 2021... Migraine 20 Jun, 2021 Read Time: 4 mins Satellite symposium Migraine management conundrums—the data can help What is the best management for patients with migraine if they have cardiovascular disease or if they... Migraine 20 Jun, 2021 Read Time: 4 mins Congress highlights Real world evidence for CGRP antibodies in migraine prevention In a topical symposium at #EAN2021, three speakers discussed what is new on targeting CGRP for... Migraine, Alzheimer's Disease 19 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 2 The exciting live and connected virtual experience for presenters and attendees of the 7th Congress... Migraine, Alzheimer's Disease 19 Jun, 2021 Read Time: 3 mins Congress highlights Highlights from EAN 2021 — Day 1 Welcome to Progress in Mind’s live coverage of EAN 2021. This 7th Congress of the European Academy of... Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page » Schizophrenia 16 Apr, 2020 Read Time: 3 mins Article Pandemic brings challenge and opportunity for people with schizophrenia The COVID-19 pandemic risks exacerbating symptoms in people prone to experience reality in unusual... Mental Health 06 Apr, 2020 Read Time: 2 mins Article Practical support for mental health in time of crisis Many people with mental health diseases will experience additional emotional distress when faced with... Schizophrenia 23 Mar, 2020 What is Schizophrenia? Depression, Schizophrenia 19 Mar, 2020 Read Time: 2 mins Interview Early intervention services have the potential to improve the success of treatment and social functioning for individuals with schizophrenia Schizophrenia is a heterogenous, progressive and recurrent disease with multiple dimensions which can... Schizophrenia 10 Mar, 2020 Improvement in schizophrenia: Long and short term perspectives Schizophrenia 27 Jan, 2020 Read Time: 3 mins Article The neurobiology of conversion to psychosis – emerging findings from the SHARP study The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to... Schizophrenia 13 Jan, 2020 Read Time: 0 min Interview John FP Bridges - Changing the paradigm: putting patient treatment goals at the center Schizophrenia 08 Jan, 2020 Read Time: 0 min Interview John FP Bridges - Aiming for recovery: the world before Schizophrenia Schizophrenia 15 Oct, 2019 Read Time: 3 mins Satellite symposium Improving treatment outcomes in schizophrenia: Looking beyond positive symptoms for early and effective intervention Although the symptoms of schizophrenia are troublesome for almost all persons with the disease, its... Schizophrenia 12 Aug, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page » Most Popular Depression 12 May, 2023 Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM?